Lilly (LLY) Completes Acquisition of POINT Biopharma (PNT) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Eli Lilly has announced the successful completion of its acquisition of POINT Biopharma Global, a company with a pipeline of therapies in development for the treatment of cancer.Next-generation.
Eli Lilly Completes Acquisition of POINT Biopharma themiddlemarket.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themiddlemarket.com Daily Mail and Mail on Sunday newspapers.
Novartis, Lilly drive investor interest in radiopharmaceuticals fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Eli Lilly’s Jaypirca is now approved for treating three types of blood cancers. While Jaypirca blocks a target already addressed by other cancer therapies, the Lilly molecule does it in a way that sets it apart from the rest of its drug class.